The US Justice Department sued Walmart over its role in the opioid crisis, alleging irresponsible handling of orders, wrongly filling thousands of prescriptions, and ignoring warning signs about problem orders to boost sales.
Up to billions of dollars in penalties could be sought in the litigation that followed a multi-year investigation.
According to Jeffrey Bossert Clark, acting head of the Justice Department's civil division, Walmart had the responsibility and the means to help prevent the diversion of prescription opioids but instead did the opposite by filling thousands of invalid prescriptions and failing to report suspicious opioid orders.
The government lawsuit said Walmart managers enormously pressured pharmacists to fill prescriptions and that it withheld the information from pharmacists on data on invalid controlled-substance prescriptions.
Walmart claimed the charges were baseless and accused US authorities of shifting blame from the Drug Enforcement Administration's failures in keeping bad doctors from prescribing opioids. It added that the complaint was "riddled with factual inaccuracies."
According to the Centers for Disease Control and Prevention, nearly 450,000 Americans died between 1999 and 2018 from overdoses due to prescription and illegal opioids.


Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings 



